The tertiary HVAC project (offices, hospitality, large retail, healthcare facilities, educational infrastructure) has a decision cycle distinct from that of residential installation. The technical specification is closed during the project phase, with the installations engineering and the design team. The actual purchase of the equipment, by contrast, occurs during the construction phase, when the contractor and installer award the supply. Between both phases a year may elapse.
The manufacturer that wins technical prescription in the project phase delivers documentation to the engineering function, technical validation to the designer and, in many cases, assistance in drafting the installations memorandum. That phase concludes with the brand incorporated into the construction specification. The emotional conclusion of the typical sales team is that the project is closed. The operational conclusion is the opposite: what remains is the longest part of the cycle, where the brand can be substituted.
During the months between construction award and actual equipment purchase, several pressures operate simultaneously. The contractor negotiates with installers who have their own brand preferences. The winning installer may propose an equivalent alternative with more favourable spot conditions. The contractor's buyer, without independent technical judgement, typically accepts the installer's proposal. The prescribed brand falls without the designer knowing or the manufacturer reacting.
The reverse pattern is viable. Companies that maintain high conversion rates between prescription and purchase in tertiary HVAC execute active presence throughout the intermediate period. Explicit project tracking from construction award through to order. Direct relationship with the main contractor and with the winning installer. Differentiated operational conditions that reduce the incentive for substitution. And a prescription defence mechanism that operates with the same rigour as the initial capture phase.
The frequent error consists in structuring the sales team into two watertight compartments: technical prescription and installer. The former wins the project, hands it to the specification and reallocates its time to the next. The latter receives the installer when the latter already has the construction awarded and, frequently, already has an alternative brand preference formed. The discontinuity between both teams is where prescription is lost.
Three components define a functional prescription defence system in tertiary HVAC. A database of specified projects with estimated construction timelines and end-to-end assigned commercial lead. An early contact mechanism with contractor and winning installer as soon as the construction closes, before the competitor arrives with a substitution proposal. And operational conditions that reward fidelity to the prescribed brand: immediate availability, installation support, specific installer training.
A complementary observation affects the sales metric. The typical close rate counts closed projects as a percentage of submitted projects, but does not distinguish between projects where the company was prescribed and projects where it arrived as an alternative. Without that segmentation, management reads as loss of market share what is in reality loss of defensible prescription.
Three concrete levers remain available to general management. Unify responsibility for the complete project cycle in a single account interlocutor, from technical office phase through to equipment delivery. Build the conversion analytics between prescription and purchase, segmented by project type, drafting engineering and geography. And equip the sales team with authority to condition the operational decisions (stock, lead times, training) that differentiate the prescribed brand from the alternative.
Winning technical prescription in tertiary HVAC is the visible phase of the sales process. Defending it during the subsequent year is the silent phase that decides market share. The manufacturer that only manages the former systematically sells less than it prescribes.